DAGOBERT SIMO: Open Payments
NPI 1144458217 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 10 payments from 5 companies in 2025. Trend: 2023 $76 · 2024 $34 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $87 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
| Orexo US, Inc. | 1 | $15 |
| Indivior Inc. | 1 | $14 |
Products named: Rybelsus, Ozempic, MOUNJARO, The Cologuard Plus Collection Kit, JARDIANCE, Cologuard Collection Kit, Zubsolv, SUBLOCADE.
Industry payments across MD — which companies pay providers there.
